secwatch.observer — SEC 8-K summary
======================================

Issuer:     KEMPER Corp (KMPR)
CIK:        0000860748
Form:       8-K
Filed at:   2023-03-09T23:59:59+00:00
Accession:  0000860748-23-000068
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kemper investor day outlines path to 2024 target returns, $150M+ cost savings by 2025
--------------------------------------------------------------------------------

- Aims for positive adjusted net operating profit in 1H'23 and underwriting profit in 2H'23; targets 10-12% ROE and 14-16% ROATCE by 2024.
- Cost optimization: $150M+ annualized run-rate savings by end 2025; $36M in charges incurred to date on $61M realized savings.
- Specialty P&C filed 43 points of rate since 2Q'21; expects >13% additional rate to earn-in through 2023; YE 2023 underlying combined ratio target 97-100%.
- Investor day reaffirms focus on specialty auto and life; completed sale of Kemper Health (Reserve National) on 12/1/22.
- Macro tailwinds cited: rising interest rates, declining mortality, moderating severity inflation improving profit outlook.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860748/000086074823000068/0000860748-23-000068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860748/000086074823000068/kmpr-20230309.htm
  HTML page:      https://secwatch.observer/filing/0000860748-23-000068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer